TLR4 and schizophrenia: Among AP-medicated persons with schizophrenia [28,30,33,36], two studies found no significant difference between persons with schizophrenia and HCs [28,30], one study reported a lower percentage [33], and one reported a greater proportion of TLR4+ monocytes in persons with schizophrenia than in HCs [36].